Compare NNVC & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNVC | PRA |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 1.3B |
| IPO Year | 2008 | 2000 |
| Metric | NNVC | PRA |
|---|---|---|
| Price | $1.75 | $24.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 971.2K | 877.3K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.00 | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $1,098,028,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $149.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $22.79 |
| 52 Week High | $2.23 | $24.85 |
| Indicator | NNVC | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 30.34 |
| Support Level | $1.26 | $23.88 |
| Resistance Level | $1.87 | $24.16 |
| Average True Range (ATR) | 0.18 | 0.17 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 64.94 | 25.00 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.